Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neoplasm Metastasis × Denosumab × Clear all

Status

Completed 4 Unknown 1 Terminated 1 Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Giant Cell Tumor of Bone 2 Thyroid Cancer Metastatic 1 Osteoporotic Fractures 1 Osteoporosis 1 Osteoblastoma 1 Neoplasm Metastasis 1 Musculoskeletal Pain 1 Melanoma 1 Kidney Neoplasms 1 Granuloma, Giant Cell 1 Chondroblastoma 1 Carcinoma, Renal Cell 1 Breast Neoplasms 1 Bone Metastasis From Solid Tumors 1 Bone Metastases From Solid Tumors 1 Bone Metastases 1 Bone Cysts, Aneurysmal 1 Arthralgia 1

Interventions

Fluorouracil 18 Oxaliplatin 15 Capecitabine 15 Leucovorin 13 Irinotecan 11 Gemcitabine 11 Drug Therapy 11 Cetuximab 10 Radiosurgery 9 Cisplatin 9 Bevacizumab 9 Docetaxel 8 Radiotherapy 6 Paclitaxel 6 Neoadjuvant Therapy 6 Everolimus 6 spartalizumab 5 pembrolizumab 5 Trastuzumab 5 Sunitinib 5 S 1 (combination) 5 Cyclophosphamide 5 Chemotherapy, Adjuvant 5 Carboplatin 5 manganese chloride 4 Surgical Procedures, Operative 4 Sorafenib 4 Nivolumab 4 Immunotherapy 4 Immune Checkpoint Inhibitors 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05435768 2022-08-18

PRaG 2X

Second Affiliated Hospital of Soochow University

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡